Development of chemotherapy and significance of conversion surgery after chemotherapy in unresectable pancreatic cancer

While surgery currently remains the only potentially curative treatment available for pancreatic cancer, only 20% to 30% of patients have resectable disease at diagnosis. Recently, with the introduction of intensive chemotherapy regimens such as oxaliplatin, irinotecan, fluorouracil plus leucovorin...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of hepato-biliary-pancreatic sciences Jg. 25; H. 5; S. 261 - 268
Hauptverfasser:	Furuse, Junji, Shibahara, Junji, Sugiyama, Masanori
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Japan Wiley Subscription Services, Inc 01.05.2018
Schlagworte:	Adult Aged Antineoplastic Combined Chemotherapy Protocols - therapeutic use Cancer therapies Chemotherapy Disease-Free Survival Distant metastasis Female Humans Male Metastasis Middle Aged Neoadjuvant Therapy - methods Neoplasm Invasiveness - pathology Neoplasm Staging Pancreatectomy - methods Pancreatectomy - mortality Pancreatic cancer Pancreatic Neoplasms - mortality Pancreatic Neoplasms - pathology Pancreatic Neoplasms - therapy Prognosis Risk Assessment Surgery Surgical resection Survival Analysis Distant metastasis Surgical resection Chemotherapy Pancreatic cancer
ISSN:	1868-6974, 1868-6982, 1868-6982
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!